Quick10K

⚲

Heron Lake Bioenergy

Filings

10-Q	2021-01-31	Filed 2021-03-17
10-K	2020-10-31	Filed 2021-02-16
10-Q	2020-07-31	Filed 2020-09-14
10-Q	2020-04-30	Filed 2020-06-15
10-Q	2020-01-31	Filed 2020-03-16
10-K	2019-10-31	Filed 2020-01-29
10-Q	2019-07-31	Filed 2019-09-16
10-Q	2019-04-30	Filed 2019-06-14
10-Q	2019-01-31	Filed 2019-03-18
10-K	2018-10-31	Filed 2019-01-29
10-Q	2018-07-31	Filed 2018-09-14
10-Q	2018-04-30	Filed 2018-06-14
10-Q	2018-01-31	Filed 2018-03-19
10-K	2017-10-31	Filed 2018-01-29
10-Q	2017-07-31	Filed 2017-09-14
10-Q	2017-04-30	Filed 2017-06-14
10-Q	2017-01-31	Filed 2017-03-17
10-K	2016-10-31	Filed 2017-01-30
10-Q	2016-07-31	Filed 2016-09-14
10-Q	2016-04-30	Filed 2016-06-14
10-Q	2016-01-31	Filed 2016-03-16
10-K	2015-10-31	Filed 2016-01-28
10-Q	2015-07-31	Filed 2015-09-14
10-Q	2015-04-30	Filed 2015-06-15
10-Q	2015-01-31	Filed 2015-03-16
10-K	2014-10-31	Filed 2015-01-28
10-Q	2014-07-31	Filed 2014-09-16
10-Q	2014-04-30	Filed 2014-06-16
10-Q	2014-01-31	Filed 2014-03-17
10-K	2013-10-31	Filed 2014-01-29
10-Q	2013-07-31	Filed 2013-09-16
10-Q	2013-04-30	Filed 2013-07-01
10-Q	2013-01-31	Filed 2013-06-11
10-K	2012-10-31	Filed 2013-02-13
10-Q	2012-07-31	Filed 2012-09-14
10-Q	2012-04-30	Filed 2012-06-14
10-Q	2012-01-31	Filed 2012-03-16
10-K	2011-10-31	Filed 2012-01-30
10-Q	2011-07-31	Filed 2011-09-14
10-Q	2011-04-30	Filed 2011-06-14
10-Q	2011-01-31	Filed 2011-03-15
10-K	2010-10-31	Filed 2011-01-21
10-Q	2010-07-31	Filed 2010-08-25
10-Q	2010-04-30	Filed 2010-06-14
10-Q	2010-01-31	Filed 2010-03-17
10-K	2009-10-31	Filed 2010-01-29

Reports

8-K	2020-06-19
8-K	2020-04-29
8-K	2020-03-19
8-K	2020-03-18
8-K	2019-12-23
8-K	2019-10-29
8-K	2019-10-22
8-K	2019-10-04
8-K	2019-05-07
8-K	2019-03-25
8-K	2018-12-19
8-K	2018-07-25
8-K	2018-04-09
8-K	2018-03-27

Heron Lake Bioenergy Financials

C964 Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin


Comps ($'000 TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)


Balance Sheet ($'000)	2011-07-31	2011-10-31	2012-01-31	2012-04-30	2012-07-31	2012-10-31	2013-01-31	2013-04-30	2013-07-31	2013-10-31	2014-01-31	2014-04-30	2014-07-31	2014-10-31	2015-01-31	2015-04-30	2015-07-31	2015-10-31	2016-01-31	2016-04-30	2016-07-31	2016-10-31	2017-01-31	2017-04-30	2017-07-31	2017-10-31	2018-01-31	2018-04-30	2018-07-31	2018-10-31	2019-01-31	2019-04-30	2019-07-31
Cash	4,479	7,141	2,567	1,337	1,683	653	749	889	1,023	543	1,198	6,256	1,152	662	624	632	1,813	1,126	1,167	951	1,213	1,298	1,111	7,204	7,718	10,065	1,011	4,223	5,605	5,996	3,265	3,438	6,044
Accounts Receivable	6,511	1,378	348	1,346	859	1,785	2,050	1,427	3,005	749	6,048	6,433	6,802	4,056	831	4,465	1,189	5,671	4,747	1,194	5,951	4,607	3,973	360	1,750	4,032	4,025	3,687	1,716	3,953	1,584	3,715	761
Inventory	9,605	3,765	4,013	2,597	2,781	3,589	3,184	2,427	2,303	5,604	4,047	4,233	6,201	5,187	6,146	4,822	6,473	5,259	5,493	4,961	4,020	5,865	6,764	5,648	6,448	7,064	7,702	6,089	6,516	6,399	7,439	5,580	8,830
PP&E	110,494	112,158	112,934	114,503	114,048	87,322	87,540	81,651	81,751	83,005	83,638	83,835	85,704	89,977	90,788	91,405	53,437	93,149	52,343	52,041	51,410	95,284	49,596	48,598	47,676	96,331	45,588	44,591	45,081	98,866	42,928	41,721	40,375
Assets	111,859	104,134	98,302	96,308	94,123	66,581	65,605	59,781	60,754	60,794	65,021	69,141	66,700	66,122	63,469	64,891	65,297	66,696	65,383	60,699	64,651	63,771	62,871	63,317	65,044	68,873	59,687	60,445	60,390	62,021	56,700	55,946	57,682
Accounts Payable	1,556	2,705	1,852	1,955	803	2,086	1,796	947	937	1,301	2,000	3,803	4,744	7,048	6,122	2,970	2,307	3,914	2,056	2,580	2,459	4,878	2,363	2,292	3,007	4,771	2,371	2,343	2,663	5,414	2,278	2,477	4,173
Long-Term Debt	52,019	51,418	46,796	46,154	45,867	46,083	46,615	42,595	23,489	31,553	29,026	24,943	10,728	2,959	6,168	12,239	6,949	7,230	8,121	7,055	7,190	1,884	1,755	1,726	1,559	1,398	1,287	1,276	1,118	959	951	947	791
Liabilities	61,531	54,626	49,565	48,927	47,212	49,237	49,181	44,355	35,851	33,652	32,054	29,851	-11,232	11,075	16,894	16,583	13,180	14,250	16,858	12,188	13,329	10,271	6,539	5,966	6,278	8,105	6,625	6,113	5,754	8,966	5,668	6,030	7,439
Stockholders' Equity	50,328	49,508	48,737	47,381	46,911	17,344	16,424	15,426	24,903	27,142	32,967	39,290	77,932	55,047	46,575	48,308	52,117	52,446	48,524	48,511	51,322	53,500	56,332	57,351	58,766	60,768	53,062	54,333	54,635	53,055	51,031	49,916	50,243


Income Statement ($'000)	2011-07-31	2011-10-31	2012-01-31	2012-04-30	2012-07-31	2012-10-31	2013-01-31	2013-04-30	2013-07-31	2013-10-31	2014-01-31	2014-04-30	2014-07-31	2014-10-31	2015-01-31	2015-04-30	2015-07-31	2015-10-31	2016-01-31	2016-04-30	2016-07-31	2016-10-31	2017-01-31	2017-04-30	2017-07-31	2017-10-31	2018-01-31	2018-04-30	2018-07-31	2018-10-31	2019-01-31	2019-04-30	2019-07-31
Revenue	43,014	43,884	38,862	41,186	40,972	47,640	44,121	35,499	45,583	38,560	40,911	39,149	39,082	30,276	27,177	29,814	30,192	28,477	26,589	25,242	30,365	27,410	27,390	25,991	28,542	27,995	27,972	29,881	26,253	24,366	25,698	25,495	27,368
Cost of Revenue	42,325	42,683	38,597	40,084	39,987	47,861	43,201	34,800	41,523	35,969	33,730	31,547	30,790	24,502	25,330	27,140	25,436	27,341	25,731	24,322	26,635	24,425	23,976	24,141	26,291	25,081	26,391	27,753	25,161	25,075	26,731	25,914	26,120
Gross Profit	689	1,201	265	1,102	985	-1,158	920	699	4,060	2,592	7,181	10,723	8,292	5,774	1,847	2,674	4,756	1,136	858	920	3,730	2,985	3,414	1,850	2,251	2,913	1,581	2,128	1,092	-709	-1,034	-420	1,248
R&D
SG&A	871		851	863	715				674		840	1,009	777		880	782	742
Tax
Net Income	-725	-830	-1,231	-1,267	-379	-29,475	-829	-922	2,642	1,377	5,934	9,689	6,876	5,121	943	1,797	3,844	329	58	46	2,846	2,178	2,915	1,077	1,448	2,076	978	1,356	338		-1,932	-1,045	362


Cash Flow ($'000)	2011-07-31	2011-10-31	2012-01-31	2012-04-30	2012-07-31	2012-10-31	2013-01-31	2013-04-30	2013-07-31	2013-10-31	2014-01-31	2014-04-30	2014-07-31	2014-10-31	2015-01-31	2015-04-30	2015-07-31	2015-10-31	2016-01-31	2016-04-30	2016-07-31	2016-10-31	2017-01-31	2017-04-30	2017-07-31	2017-10-31	2018-01-31	2018-04-30	2018-07-31	2018-10-31	2019-01-31	2019-04-30	2019-07-31
Cash Operating			32	980	636	-1,251	262	352		1,319	3,816	9,325	7,054	8,124	3,217	-1,748	4,801	261	339	5,510	767	5,333	1,512	6,870		2,715	-1,049	4,424	2,352		-2,631	228	2,826
Cash Investing			-776	-244	-1,425	883	-218	3,779		-648	-634	-185	-1,880	-846	-538	-890	-972	-422	-718	-315	-1,132	-319	-341	-110		-207	-209	-237	-812		-93	-50	-64
Cash Financing			-3,830	-1,966	1,135	-662	52	-3,992		-1,151	-2,527	-4,083	-10,279	-7,768	-2,717	2,645	-2,648	-525	419	-5,410	627	-4,929	-1,359	-666		-161	-7,797	-974	-158		-8	-4	-157